Active ingredientEtimicin SulphateCat. No. P-E131-001CAS 362045-44-1Family · Pharmaceutical analytical standards
Etimicin
A semi-synthetic aminoglycoside, 1-N-ethylgentamicin C1a, developed in the early 1990s at the Jiangsu Institute of Microbiology in China, where it came into wide clinical use against bacterial infections. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?A study in rats and cells, carried out between China and New Zealand, indicates that it does very little harm to the kidneys and ear because it accumulates less in the mitochondria of target cells.
Go to the active ingredient →Active ingredientEtimicin SulphateCat. No. P-E131-001CAS 362045-44-1
Isotopically labelledEtimicin-D5Cat. No. P-E131-004
ImpurityEtimicin Impurity 1Cat. No. P-E131-005
ImpurityEtimicin Impurity 2Cat. No. P-E131-006CAS 1312695-19-4
ImpurityEtimicin Impurity 3Cat. No. P-E131-007CAS 1312695-18-3
ImpurityEtimicin Impurity 4Cat. No. P-E131-008CAS 160296-30-0
ImpurityEtimicin Impurity 5Cat. No. P-E131-009CAS 1912378-28-9
ImpurityEtimicin Impurity 6Cat. No. P-E131-010
ImpurityEtimicin Impurity 7Cat. No. P-E131-011No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.